Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the pregnyl market size evolved in recent years?
The dimension of the pregnyl market has been discernibly expanding with XX (HCAGR) in the last couple of years. It is forecasted to surge from $XX million in 2024 to $XX million in 2025, flaunting a compound annual growth rate (CAGR) of XX%. The significant expansion in the historic timeline can be linked to the growing number of infertility cases, enhanced consciousness regarding assisted reproductive technologies, the upward trend in the utilization of hCG-centric treatments for hypogonadism, better access to fertility clinics, supportive governmental policies towards reproductive wellness, and the escalating demand for treatments enhancing male fertility.
What are the predictions for the pregnyl market size in the coming years?
The dimension of the pregnyl market is projected to witness a XX compound annual growth rate (CAGR) in the upcoming years, escalating to $XX million by 2029. The expansion projected in this period can be linked to factors such as growing infertility rates, increased demand for methods like assisted reproductive technologies, heightened awareness about hormonal disorders, extended healthcare accessibility in emerging markets, augmented implementation of hCG for male fertility, and increasing healthcare costs. Key trends expected during this forecast period consist in advancements in drug formulation and delivery systems, improved dosage accuracy, innovative combination therapies, the incorporation of user-friendly packaging, along with the rise of telemedicine for distant fertility management.
Get your pregnyl market report here!
https://www.thebusinessresearchcompany.com/report/pregnyl-global-market-report
What key factors are fueling the growth of the pregnyl market?
The pregnyl market is projected to expand due to the increasing prevalence of male hypogonadism. This condition results from insufficient production of testosterone, a vital hormone for male growth and development, or inadequate sperm creation. The escalation in male hypogonadism cases is attributed mainly to ageing populations, growing obesity rates, and exposure to environmental pollutants. Pregnyl is beneficial in treating male hypogonadism by providing human chorionic gonadotropin (hCG), which prompts the testes to generate testosterone and facilitate spermatogenesis. This helps to correct hormonal imbalances, elevates testosterone levels, and restores men’s fertility impacted by hypogonadism. For example, the Endocrine Society, a non-profit organization based in the US, reported in January 2022, that about 35% of men over 45 and 30-50% of men affected by obesity or type 2 diabetes undergo hypogonadism. Hence, this increasing prevalence of male hypogonadism constitutes a key growth driver in the pregnyl market.
How is the global pregnyl market divided into key segments?
The pregnyl market covered in this report is segmented –
1) By Indication: Fertility Treatments In Women; Male Infertility; Hypogonadotropic Hypogonadism
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End-User: Fertility Clinics; Research Institutions; Other End-Users
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20262&type=smp
Who are the key firms paving the way for growth in the pregnyl market?
Major companies operating in the pregnyl market are Merck & Co.Inc.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20262
What regions are contributing significantly to the growth of the pregnyl market?
North America was the largest region in the pregnyl market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pregnyl market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Infertility Treatment Global Market Report 2025
https://thebusinessresearchcompany.com/report/infertility-treatment-global-market-report
Ovulation Inducing Drugs Global Market Report 2025
https://thebusinessresearchcompany.com/report/ovulation-inducing-drugs-global-market-report
Women’s Digital Health Global Market Report 2025
https://thebusinessresearchcompany.com/report/womens-digital-health-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
